Macrophage‐Specific Hypoxia‐Inducible Factor‐1α Contributes to Impaired Autophagic Flux in Nonalcoholic Steatohepatitis

  • Xiaojing Wang
    Department of Medicine,University of Massachusetts Medical School,Worcester,MA
  • Marcelle de Carvalho Ribeiro
    Department of Medicine,University of Massachusetts Medical School,Worcester,MA
  • Arvin Iracheta‐Vellve
    Department of Medicine,University of Massachusetts Medical School,Worcester,MA
  • Patrick Lowe
    Department of Medicine,University of Massachusetts Medical School,Worcester,MA
  • Aditya Ambade
    Department of Medicine,University of Massachusetts Medical School,Worcester,MA
  • Abhishek Satishchandran
    Department of Medicine,University of Massachusetts Medical School,Worcester,MA
  • Terence Bukong
    Department of Medicine,University of Massachusetts Medical School,Worcester,MA
  • Donna Catalano
    Department of Medicine,University of Massachusetts Medical School,Worcester,MA
  • Karen Kodys
    Department of Medicine,University of Massachusetts Medical School,Worcester,MA
  • Gyongyi Szabo
    Department of Medicine,University of Massachusetts Medical School,Worcester,MA

抄録

<jats:p>Inflammatory cell activation drives diverse cellular programming during hepatic diseases. Hypoxia‐inducible factors (HIFs) have recently been identified as important regulators of immunity and inflammation. In nonalcoholic steatohepatitis (NASH), HIF‐1α is upregulated in hepatocytes, where it induces steatosis; however, the role of HIF‐1α in macrophages under metabolic stress has not been explored. In this study, we found increased HIF‐1α levels in hepatic macrophages in methionine‐choline‐deficient (MCD) diet‐fed mice and in macrophages of patients with NASH compared with controls. The HIF‐1α increase was concomitant with elevated levels of autophagy markers BNIP3, Beclin‐1, LC3‐II, and p62 in both mouse and human macrophages. LysM<jats:sup>Cre</jats:sup> HIF<jats:sup>dPA</jats:sup>fl/fl mice, which have HIF‐1α levels stabilized in macrophages, showed higher steatosis and liver inflammation compared with HIF<jats:sup>dPA</jats:sup>fl/fl mice on MCD diet. <jats:italic toggle="yes">In vitro</jats:italic> and <jats:italic toggle="yes">ex vivo</jats:italic> experiments reveal that saturated fatty acid, palmitic acid (PA), both induces HIF‐1α and impairs autophagic flux in macrophages. Using small interfering RNA–mediated knock‐down and overexpression of HIF‐1α in macrophages, we demonstrated that PA impairs autophagy via HIF‐1α. We found that HIF‐1α mediates NF‐κB activation and MCP‐1 production and that HIF‐1α—mediated impairment of macrophage autophagy increases IL‐1β production, contributing to MCD diet‐induced NASH. <jats:italic toggle="yes">Conclusion</jats:italic>: Palmitic acid impairs autophagy via HIF‐1α activation in macrophages. HIF‐1α and impaired autophagy are present in NASH <jats:italic toggle="yes">in vivo</jats:italic> in mouse macrophages and in human blood monocytes. We identified that HIF‐1α activation and decreased autophagic flux stimulate inflammation in macrophages through upregulation of NF‐κB activation. These results suggest that macrophage activation in NASH involves a complex interplay between HIF‐1α and autophagy as these pathways promote proinflammatory overactivation in MCD diet‐induced NASH.</jats:p>

収録刊行物

  • Hepatology

    Hepatology 69 (2), 545-563, 2019-01-04

    Ovid Technologies (Wolters Kluwer Health)

被引用文献 (1)*注記

もっと見る

キーワード

問題の指摘

ページトップへ